Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3015% below fair value
$1.94−0.10 (-4.90%)
Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –
Niagen Bioscience price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Niagen Bioscience's price to book ratio was 2.0× on Nov 11, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 2.0× to 20.4×, with a median of 5.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | −5.2 |
| 2025 | Dec 31, 2025 | 7.2× | −4.6 |
| 2024 | Dec 31, 2024 | 11.7× | +7.8 |
| 2023 | Dec 29, 2023 | 3.9× | −1.5 |
| 2022 | Dec 30, 2022 | 5.4× | −1.7 |
| 2021 | Dec 31, 2021 | 7.2× | +7.2 |
| 2020 | Dec 31, 2020 | 0.0× | +0.0 |
| 2019 | Dec 31, 2019 | 0.0× | +0.0 |
| 2018 | Dec 31, 2018 | 0.0× | −8.3 |
| 2017 | Dec 29, 2017 | 8.3× | −2.2 |
| 2016 | Dec 30, 2016 | 10.5× | −22.8 |
| 2015 | Dec 31, 2015 | 33.3× | +11.9 |
| 2014 | Dec 31, 2014 | 21.3× | −13.7 |
| 2013 | Dec 31, 2013 | 35.1× | +25.8 |
| 2012 | Dec 31, 2012 | 9.3× | +0.5 |
| 2011 | Dec 30, 2011 | 8.8× | – |
See a number that looks wrong?